CVE-2007-3253

Description

Multiple unspecified vulnerabilities in Astaro Security Gateway (ASG) before 7.005 allow remote attackers to cause a denial of service via (1) certain email, which stops the SMTP Proxy during scanning; (2) certain HTTP traffic, which stops or slows down the HTTP proxy during HTTP responses containing virus scanned web pages; and (3) a disconnection during a streaming session.

7.8

CVSS

Severity: High

CVSS 2.0 •

EPSS 1.74% Top 20%

Vendor Advisory secunia.com

Affected: n/a n/a

References

Link	Tags
http://up2date.astaro.com/2007/06/up2date_7005_released_middle.html
http://osvdb.org/37346	vdb entry
http://secunia.com/advisories/25694	third party advisory patch vendor advisory
http://osvdb.org/37345	vdb entry
https://exchange.xforce.ibmcloud.com/vulnerabilities/34884	vdb entry
http://www.securityfocus.com/bid/24492	vdb entry
http://www.vupen.com/english/advisories/2007/2220	vdb entry
https://exchange.xforce.ibmcloud.com/vulnerabilities/34882	vdb entry

Frequently Asked Questions

What is the severity of CVE-2007-3253?: CVE-2007-3253 has been scored as a high severity vulnerability.
How to fix CVE-2007-3253?: To fix CVE-2007-3253, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2007-3253 being actively exploited in the wild?: It is possible that CVE-2007-3253 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.